VSee Health (VSEE) Competitors $1.21 -0.08 (-6.20%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.33 +0.12 (+9.92%) As of 08/1/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSEE vs. BRTX, SSY, MGRX, BGLC, DHAC, ACON, ATIP, OTRK, NIVF, and OPGNShould you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), Mangoceuticals (MGRX), BioNexus Gene Lab (BGLC), Digital Health Acquisition (DHAC), Aclarion (ACON), ATI Physical Therapy (ATIP), Ontrak (OTRK), NewGenIvf Group (NIVF), and OpGen (OPGN). These companies are all part of the "healthcare" industry. VSee Health vs. Its Competitors Biorestorative Therapies SunLink Health Systems Mangoceuticals BioNexus Gene Lab Digital Health Acquisition Aclarion ATI Physical Therapy Ontrak NewGenIvf Group OpGen VSee Health (NASDAQ:VSEE) and Biorestorative Therapies (NASDAQ:BRTX) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment. Do institutionals and insiders hold more shares of VSEE or BRTX? 1.0% of VSee Health shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 6.6% of VSee Health shares are held by insiders. Comparatively, 25.5% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is VSEE or BRTX more profitable? VSee Health has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. VSee Health's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets VSee HealthN/A N/A N/A Biorestorative Therapies -3,093.61%-129.47%-86.02% Do analysts prefer VSEE or BRTX? VSee Health currently has a consensus target price of $5.00, suggesting a potential upside of 313.22%. Biorestorative Therapies has a consensus target price of $18.00, suggesting a potential upside of 1,176.60%. Given Biorestorative Therapies' higher possible upside, analysts plainly believe Biorestorative Therapies is more favorable than VSee Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Biorestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer VSEE or BRTX? In the previous week, VSee Health's average media sentiment score of 0.00 equaled Biorestorative Therapies'average media sentiment score. Company Overall Sentiment VSee Health Neutral Biorestorative Therapies Neutral Which has better earnings and valuation, VSEE or BRTX? VSee Health has higher earnings, but lower revenue than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVSee HealthN/AN/A-$4.41MN/AN/ABiorestorative Therapies$400K26.44-$8.98M-$1.47-0.96 SummaryVSee Health beats Biorestorative Therapies on 6 of the 11 factors compared between the two stocks. Get VSee Health News Delivered to You Automatically Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSEE vs. The Competition Export to ExcelMetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket CapN/A$19.20B$29.20B$9.51BDividend YieldN/A2.95%3.08%4.09%P/E RatioN/A85.9248.0923.80Price / SalesN/A154.481,544.9766.58Price / CashN/A92.4138.0757.96Price / Book-0.368.087.415.55Net Income-$4.41M$341.62M$782.10M$259.03M7 Day Performance-9.02%-6.55%-3.65%-4.59%1 Month Performance1.68%0.45%-0.11%4.46%1 Year Performance-71.53%56.29%52,642.35%18.03% VSee Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSEEVSee Health1.3304 of 5 stars$1.21-6.2%$5.00+313.2%-50.2%$0.00N/A0.00N/AGap UpHigh Trading VolumeBRTXBiorestorative Therapies3.5106 of 5 stars$1.53-2.5%$18.00+1,076.5%-7.8%$11.48M$400K-1.047SSYSunLink Health Systems1.7152 of 5 stars$1.24-6.1%N/A+22.4%$8.73M$31.09M8.861,376Gap UpMGRXMangoceuticalsN/A$1.63-4.7%N/A-98.0%$8.43M$620K-0.353Positive NewsBGLCBioNexus Gene Lab0.319 of 5 stars$4.46-2.0%N/A+43.2%$8.02M$9.27M0.0030News CoverageShort Interest ↑Gap DownDHACDigital Health AcquisitionN/A$1.33-2.2%N/A-43.8%$4.79MN/A0.002,021Gap UpACONAclarion1.4909 of 5 stars$7.71-1.7%$11,758.50+152,409.7%-99.7%$4.47M$50K0.007Positive NewsATIPATI Physical Therapy0.1268 of 5 stars$0.68+87.5%N/A-89.1%$2.98M$741.86M-0.045,600News CoverageGap UpOTRKOntrak2.1483 of 5 stars$0.49-6.9%$24.00+4,800.0%-92.0%$2.07M$10.85M-0.03250Upcoming EarningsShort Interest ↑NIVFNewGenIvf GroupN/A$0.46-11.6%N/A-99.8%$1.99M$5.43M0.00N/APositive NewsGap UpHigh Trading VolumeOPGNOpGenN/A$0.04flatN/A-98.7%$396K$2.67M0.00100Short Interest ↓ Related Companies and Tools Related Companies Biorestorative Therapies Competitors SunLink Health Systems Competitors Mangoceuticals Competitors BioNexus Gene Lab Competitors Digital Health Acquisition Competitors Aclarion Competitors ATI Physical Therapy Competitors Ontrak Competitors NewGenIvf Group Competitors OpGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSEE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VSee Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VSee Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
